Infectious disease and perinatal morbidity

Insights

Infections during pregnancy, including asymptomatic bacteriuria and genital mycoplasmas, contribute to preterm birth and low birth weight. Early screening and treatment of these infections can significantly reduce adverse perinatal outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Perinatal morbidity and mortality remain significant global health challenges, with most deaths occurring in low birth weight infants.
  • While neonatal mortality has decreased, rates of prematurity have not improved, indicating a need to address underlying causes.
  • Infections during pregnancy are increasingly recognized as a critical, yet often overlooked, factor contributing to prematurity and low birth weight.

Purpose of the Study:

  • To investigate the role of bacterial and mycoplasma infections in causing prematurity and low birth weight.
  • To evaluate the effectiveness of screening and treatment strategies for these infections in improving perinatal outcomes.
  • To highlight the importance of addressing genitourinary infections in pregnant women to reduce adverse neonatal outcomes.

Main Methods:

  • Review of existing literature on the association between urinary tract infections (UTIs), asymptomatic bacteriuria, and genital mycoplasmas with perinatal complications.
  • Analysis of studies examining the impact of treating symptomatic pyelonephritis and asymptomatic bacteriuria during pregnancy.
  • Examination of evidence regarding the role of Ureaplasma urealyticum and Mycoplasma hominis in preterm birth and the outcomes of their treatment.

Main Results:

  • Symptomatic pyelonephritis in pregnancy is linked to increased rates of prematurity, perinatal death, and long-term neurodevelopmental issues in offspring.
  • Asymptomatic bacteriuria, when untreated, elevates risks for low birth weight, perinatal mortality, and progression to symptomatic UTIs.
  • Treatment of asymptomatic bacteriuria and colonization with genital mycoplasmas (Ureaplasma urealyticum, Mycoplasma hominis) has demonstrated a significant reduction in prematurity rates.

Conclusions:

  • Genitourinary infections, both symptomatic and asymptomatic, are significant contributors to preventable perinatal morbidity and mortality.
  • Routine screening for asymptomatic bacteriuria and genital mycoplasmas, followed by appropriate treatment, is crucial for improving pregnancy outcomes.
  • Addressing infectious causes of prematurity is essential for reducing adverse neonatal outcomes and improving infant neurodevelopmental health.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Transmission of Pathogens01:24

Transmission of Pathogens

Pathogens spread from their reservoirs to susceptible hosts through three main routes: contact transmission, vehicle transmission, and vector transmission. Each route involves distinct mechanisms of transfer.Contact TransmissionThis category includes direct contact, indirect contact, and droplet transmission:Direct contact involves immediate physical interaction between individuals—such as a handshake—which can spread pathogens like Streptococcus pyogenes, the bacterium responsible for...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...